Citius Oncology stock soars on expanded AI collaboration for LYMPHIR launch
Citius Oncology stock soars on expanded AI collaboration for LYMPHIR launch
Source link
Similar Posts
Thursday: GDP, Unemployment Claims, Pending Home Sales
by Calculated Risk on 1/29/2025 08:08:00 PM Note: Mortgage rates are from MortgageNewsDaily.com and are for top tier scenarios. Thursday:• At 8:30 AM ET, Gross Domestic Product, 4th quarter and Year 2024 (Advance estimate). The consensus is that real GDP increased 2.6% annualized in Q4. • Also at 8:30 AM, The initial weekly unemployment claims…
Is Your REIT Dividend a Mirage? 5 Red Flags Hiding Behind a High DPU – My Stocks Investing
For many retail investors, the headline Distribution Per Unit (DPU) is the ultimate scorecard. It is the number that flashes on the screen, dictates the yield, and often determines whether a REIT earns a place in a retirement portfolio. However, as REIT specialist Kenny Loh warns, focusing exclusively on this headline figure can lead to…
Lupin Signs Deal with SteinCares for Ranibizumab Supply in Latin America; Shares Trading Flat
May 26, 2025May 26, 2025 Shares of Lupin Ltd are trading flat after touching a day’s high of Rs 2,004.90 on 26th May, after the company announced signing an agreement with SteinCares for the supply of Ranibizumab in Latin America. The agreement covers the licensing…
Mazagon Dock Shares Skyrocketed 12% on Stellar Q4 Earnings; Declares Dividend – Equitypandit
Shares of Mazagon Dock Shipbuilders Ltd. skyrocketed 12% and hit a 52-week high of Rs 3,403.95 on 29 May after the company’s net profit doubled for the quarter ending 31 March 2024. The company’s net profit during the quarter under review stood at Rs 663 crore, doubling from Rs 326 crore reported in the same…
Nike shares slide as guidance flags ‘severe issues’; Q2 results top estimates By Investing.com
Investing.com — Nike shares initially jumped in extended trading after the company topped expectations for the fiscal second quarter. However, the stock reversed course and declined following disappointing guidance and updates during the earnings call. Nike Inc (NYSE:) shares slumped 4% in premarket trading Friday. The sportswear giant reported Q2 earnings per share (EPS) of $0.78…
